Certified by Founder
Lodge
Lightcast Discovery
start up
United Kingdom
- Cambridge, England
- 18/08/2023
- Series B
- $49,000,000
Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function. Compared to standard microfluidic methods, the Lightcast platform offers the ability to run a broader range of assays and to precisely control and track the number, occupancy, location, and movement of each droplet. The unprecedented scalability and flexibility of this approach will help advance translational and basic research as well as streamline development workflows for drugs, therapeutics, and applied biologics.
- Industry Biotechnology Research
- Website https://www.lightcast.bio/
- LinkedIn https://www.linkedin.com/company/lightcast-discovery/about/